ConductScience.org, home

Paper9510317

Comparison of oral with rectal mesalazine in the treatment of ulcerative proctitis.

Gionchetti P and 6 others. Dis Colon Rectum, 1998. Cited by 109 papers, by iCite.

Cite this record

ConductScience Library. Comparison of oral with rectal mesalazine in the treatment of ulcerative proctitis. Papers, record 9510317. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9510317

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comparison of oral with rectal mesalazine in the treatment of ulcerative proctitis.
PubMed
Journal
Dis Colon Rectum
PubMed
Year
1998
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
109
iCite
Relative citation ratio, by iCite
3.44
iCite
Revised in PubMed
2019-07-21
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gionchetti PP
2Rizzello FF
3Venturi AA
4Ferretti MM
5Brignola CC
6Miglioli MM
7Campieri MM

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Colitis, UlcerativeMajor topic
MesalamineMajor topic
ProctitisMajor topic
Administration, Oral
Administration, Rectal
Adult
Female
Humans
Male
Single-Blind Method
Treatment Outcome

Source PubMed

Download CSV of topics

Cited by29

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 109 citations.

PMIDTitleJournalYearIn PapersSource
42688763The Proctitis Paradox: Refractory Ulcerative Proctitis Associated With Development of Disease Complications in a Multicenter South Australian Cohort.JGH Open2026https://conductscience.org/library/papers/42688763PubMed
41470757Clinical Outcomes of Oat Beta-Glucan Nutritional Intervention in Ulcerative Colitis: Case Reports of a Female and a Male Patient.Nutrients2025https://conductscience.org/library/papers/41470757PubMed
41216280Clinical features and current treatment approach to ulcerative proctitis.Transl Gastroenterol Hepatol2025https://conductscience.org/library/papers/41216280PubMed
39561101Long-Term Course and Prognostic Factors in Pediatric Ulcerative Proctitis: A Multicenter Cohort Study.Inflamm Bowel Dis2025https://conductscience.org/library/papers/39561101PubMed
38613425Efficacy and Safety of Etrasimod in Patients with Moderately to Severely Active Isolated Proctitis: Results From the Phase 3 ELEVATE UC Clinical Programme.J Crohns Colitis2024https://conductscience.org/library/papers/38613425PubMed
37901338Clinical Background Factors as Predictors of the Efficacy of 5-Aminosalicylic Acid Suppositories in Patients with Ulcerative Colitis.Inflamm Intest Dis2023https://conductscience.org/library/papers/37901338PubMed
37589498Systematic review with meta-analysis: Medical therapies for treatment of ulcerative proctitis.Aliment Pharmacol Ther2023https://conductscience.org/library/papers/37589498PubMed
36339579The application of Tong-fu therapeutic method on ulcerative colitis: A systematic review and meta-analysis for efficacy and safety of rhubarb-based therapy.Front Pharmacol2022https://conductscience.org/library/papers/36339579PubMed
36297645Advancements in Rectal Drug Delivery Systems: Clinical Trials, and Patents Perspective.Pharmaceutics2022https://conductscience.org/library/papers/36297645PubMed
34988432When disease extent is not always a key parameter: Management of refractory ulcerative proctitis.Curr Res Pharmacol Drug Discov2022https://conductscience.org/library/papers/34988432PubMed
34543327Efficacy and safety of Qingre-Chushi therapies in active ulcerative colitis: A network meta-analysis.PLoS One2021https://conductscience.org/library/papers/34543327PubMed
32646198Colitis and Crohn's Foundation (India) consensus statements on use of 5-aminosalicylic acid in inflammatory bowel disease.Intest Res2020https://conductscience.org/library/papers/32646198PubMed
322076882019 Expert opinion on biological treatment use in inflammatory bowel disease management.Turk J Gastroenterol2019https://conductscience.org/library/papers/32207688PubMed
31768387Real-World Data on Topical Therapies and Annual Health Resource Utilization in Hospitalized Swiss Patients with Ulcerative Colitis.Inflamm Intest Dis2019https://conductscience.org/library/papers/31768387PubMed
30576644AGA Clinical Practice Guidelines on the Management of Mild-to-Moderate Ulcerative Colitis.Gastroenterology2019https://conductscience.org/library/papers/30576644PubMed
30576642AGA Technical Review on the Management of Mild-to-Moderate Ulcerative Colitis.Gastroenterology2019https://conductscience.org/library/papers/30576642PubMed
29752633Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Ulcerative Colitis.Clin Pharmacokinet2019https://conductscience.org/library/papers/29752633PubMed
29429045Evidence-based clinical practice guidelines for inflammatory bowel disease.J Gastroenterol2018https://conductscience.org/library/papers/29429045PubMed
28670225Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease.Intest Res2017https://conductscience.org/library/papers/28670225PubMed
28542712Histologic scoring indices for evaluation of disease activity in ulcerative colitis.Cochrane Database Syst Rev2017https://conductscience.org/library/papers/28542712PubMed

See all 29 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9510317

GET https://conductscience.org/api/papers/v1/9510317/cited_by?page=2